Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Adv Rheumatol. 2023 Jul 19;63(1):33. doi: 10.1186/s42358-023-00315-1.
Ankylosing Spondylitis (AS) patients face several challenges due to the nature of the disease and its physical and psychological complications. Sleep disorders are among the most important concerns. Sleep disorders can aggravate the signs and symptoms of the disease and ultimately reduce the quality of patients' lives. This study uses a systematic review and meta-analysis to pool the reported prevalence of sleep disorders among AS patients.
To find related studies, the WoS, PubMed, ScienceDirect, Scopus, Embase, and Google Scholar databases were systematically searched without a lower time limit. Heterogeneity among the identified studies was checked using the I index, and the Begg and Mazumdar correlation test examined the existence of published bias. Comprehensive Meta-Analysis (v.2) software was adopted to analyze the data.
In the review of 18 studies with a sample size of 5,840, the overall pooled prevalence of sleep disorders among AS patients based on the random effects method was found to be 53% (95% CI: 44.9-61). The highest and lowest prevalence was in Egypt at 90% and Australia at 19.2%, respectively. Our meta-regression results show that with the increase in 'sample size' and 'year of publication', the overall prevalence of sleep disorders in patients with AS decreases (p < 0.05).
The results of the present study indicate a high and significant prevalence of sleep disorders among AS patients. Thus, health policymakers and healthcare providers must focus on timely diagnosis and effective educational and therapeutic interventions for the prevention and proper treatment of sleep disorders in this population of patients.
强直性脊柱炎(AS)患者由于疾病的性质及其身体和心理并发症而面临诸多挑战。睡眠障碍是最令人关注的问题之一。睡眠障碍会加重疾病的体征和症状,最终降低患者的生活质量。本研究采用系统评价和荟萃分析来汇总 AS 患者睡眠障碍的报告患病率。
为了找到相关研究,我们系统地检索了 WoS、PubMed、ScienceDirect、Scopus、Embase 和 Google Scholar 数据库,没有时间下限。使用 I 指数检查确定研究之间的异质性,并使用 Begg 和 Mazumdar 相关检验检查发表偏倚的存在。采用 Comprehensive Meta-Analysis(v.2)软件分析数据。
在对 18 项研究进行综述,样本量为 5840 例的情况下,基于随机效应方法,AS 患者睡眠障碍的总体患病率为 53%(95%CI:44.9-61)。患病率最高的是埃及(90%),最低的是澳大利亚(19.2%)。我们的荟萃回归结果表明,随着“样本量”和“发表年份”的增加,AS 患者睡眠障碍的总体患病率降低(p<0.05)。
本研究结果表明 AS 患者睡眠障碍的患病率较高且显著。因此,卫生政策制定者和医疗保健提供者必须关注及时诊断,并对这一患者群体进行有效的教育和治疗干预,以预防和适当治疗睡眠障碍。